Module

New Drugs for Treatment-Experienced Patients

Source: HIV/AIDS Annual Update 2007

New Drugs for Treatment-Experienced Patients

Faculty:
Joel E. Gallant, MD, MPH

CME CREDIT INFORMATION

Release Date: 08/06/07

Expiration Date: 08/05/08

Physicians: maximum of 1.5 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.5 contact hours (0.15 CEUs)

Registered Nurses: 1.5 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

List agents in current classes and novel classes that are under clinical development for treatment-experienced patients
Discuss data on the use of new agents in drug-resistant patients
Describe the principles guiding the use of new antiretroviral agents in the management of treatment-experienced patients

Topics covered include:

Introduction
New Agents in Currently Approved Antiretroviral Classes
New Agents in Novel Classes
Recently Approved Agents for Treatment-Experienced Patients
Investigational Agents in Existing Classes: NNRTIs
Investigational Agents in New Classes: Entry Inhibitors
Investigational Agents in New Classes: Integrase Inhibitors
Investigational Agents in New Classes: Maturation Inhibitors
The Role of Enfuvirtide With New Agents
When and How to Use a New Drug
Challenges for the Near Future: The Role of Existing and New Agents in the Coming Year
Summary: Implications for Clinical Practice

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.